Carmell Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $20 | $12 | $0 | $-3,728 |
Gross Profit | 15 | 12 | -57 | -3,728 |
EBITDA | -1,401 | -3,236 | -3,470 | 1,637 |
EBIT | -1,444 | -3,295 | -3,528 | 1,987 |
Net Income | -2,878 | -3,304 | -4,805 | 3,157 |
Net Change In Cash | 20 | 12 | 0 | -3,728 |
Free Cash Flow | 2,452 | -1,138 | -1,075 | -3,144 |
Cash | 1,137 | 2,198 | 892 | 2,912 |
Basic Shares | 20,905 | 20,735 | 22,915 | 11,021 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $0 |
Gross Profit | -124 | -242 | |
EBITDA | -15,191 | -5,254 | -1,660 |
EBIT | -15,315 | -5,496 | -1,902 |
Net Income | -15,445 | -9,051 | -6,478 |
Net Change In Cash | 0 | 0 | 0 |
Free Cash Flow | -8,378 | -3,435 | -1,184 |
Cash | 2,912 | 128 | 12 |
Basic Shares | 11,021 | 19,769 | 19,769 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-06-30 | -$0.15 |
2024-03-31 | -$0.14 |
2023-09-30 | -$0.61 |
2023-06-30 | $0.01 |
